NextGen Healthcare

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Intercept Pharmaceuticals, Inc. (Nasdaq – ICPT), Splunk, Inc. (Nasdaq – SPLK), Applied Molecular Transport Inc. (Nasdaq - AMTI), NextGen Healthcare, Inc. (Nasdaq – NX

Retrieved on:

Martedì, Settembre 26, 2023

Intercept, NextGen Healthcare, Agreement, Tripura Merger Agreement, Brodsky, CYTH, Thoma Bravo, CSCO, Splunk, Therapy, Cyclo, Security (finance), Holding company, AMT, Cisco

If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.

Key Points:

If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.
Under the terms of the agreement, Intercept will be acquired by Alfasigma S.p.A (“Alfasigma”) for $19.00 per share in cash for each share of Intercept held.
Under the terms of the Agreement, AMT will be acquired by Cyclo Therapeutics, Inc. (“Cyclo Therapeutics”) (Nasdaq - CYTH) in an all-stock transaction.
Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits.

NextGen Healthcare Supports Athletico Physical Therapy’s Growing Footprint

Retrieved on:

Lunedì, Settembre 25, 2023

NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, today announced its extended agreement with Athletico Physical Therapy (Athletico), one of the nation’s largest providers of the highest quality orthopedic rehabilitation services to communities, employers and athletes.

Key Points:

NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, today announced its extended agreement with Athletico Physical Therapy (Athletico), one of the nation’s largest providers of the highest quality orthopedic rehabilitation services to communities, employers and athletes.
NextGen® Enterprise electronic health record (EHR) and NextGen® Enterprise practice management (PM) will be used to optimize clinical and financial performance across Athletico’s newly expanded footprint.
Recognized as a national leader in exceptional patient care and outcomes, Athletico is headquartered in Oak Brook, Illinois, a suburb of Chicago.
“NextGen Healthcare has been instrumental to our ongoing pursuit of operational efficiency and excellence in patient care, and we are excited to expand this relationship,” said Chris Throckmorton , President and CEO of Athletico Physical Therapy.

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Splunk, Inc. (Nasdaq – SPLK), Applied Molecular Transport Inc. (Nasdaq - AMTI), NextGen Healthcare, Inc. (Nasdaq – NXGN), Computer Task Group, Incorporated (Nasdaq -

Retrieved on:

Giovedì, Settembre 21, 2023

Agreement, NextGen Healthcare, Tripura Merger Agreement, Brodsky, CYTH, CTG, Thoma Bravo, CSCO, Splunk, Therapy, Cyclo, Security (finance), AMT, Cisco

BALA CYNWYD, Pa., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations.

Key Points:

BALA CYNWYD, Pa., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations.
If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.
Under the terms of the Agreement, AMT will be acquired by Cyclo Therapeutics, Inc. (“Cyclo Therapeutics”) (Nasdaq - CYTH) in an all-stock transaction.
Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NXGN, WRK, AGE

Retrieved on:

Giovedì, Settembre 21, 2023

NextGen Healthcare, AgeX Therapeutics, Nextgen, WestRock, Sale, Advertising, Thoma Bravo, Fraud, Therapy, NYSE, Security (finance)

If you are a NextGen shareholder, click here to learn more about your rights and options .

Key Points:

If you are a NextGen shareholder, click here to learn more about your rights and options .
If you are a WestRock shareholder, click here to learn more about your rights and options .
Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected] .
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.

Wolters Kluwer nominates Mr. David Sides for appointment to Supervisory Board

Retrieved on:

Mercoledì, Settembre 20, 2023

Alphen aan den Rijn - September 20, 2023 - Wolters Kluwer today announced the nomination of Mr. David Sides for appointment to its Supervisory Board.

Key Points:

Alphen aan den Rijn - September 20, 2023 - Wolters Kluwer today announced the nomination of Mr. David Sides for appointment to its Supervisory Board.
The nomination follows the announced retirement of Mr. Bertrand Bodson from the Board after the AGM in May 2023.
Mr. Sides is President and CEO of NextGen Healthcare, a leading provider of innovative technology solutions focused on ambulatory care.
Chair of the Supervisory Board, Ann Ziegler, commented: “We are excited to nominate David Sides for appointment to the Supervisory Board of Wolters Kluwer given his exceptional knowledge of the healthcare sector, coupled with his financial and commercial acumen.

SHAREHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger – SOVO, WRK, NXGN, AVTA

Retrieved on:

Lunedì, Settembre 18, 2023

NextGen Healthcare, Campbell Soup Company, WestRock, Empire, Sale, Acquisition, Thoma Bravo, Monteverde, AVTA, WRK, NYSE, Security (finance)

Under the terms of the agreement, SOVO shareholders will receive $23.00 in cash per share they own.

Key Points:

Under the terms of the agreement, SOVO shareholders will receive $23.00 in cash per share they own.
It is free and there is no cost or obligation to you.
Under the terms of the agreement, NXGN shareholders are expected to receive $23.95 in cash per share they own.
Under the terms of the agreement, AVTA shareholders are expected to receive $26.00 in cash per share they own.

Moore Kuehn Encourages AGE, ACER, NXGN, and SUM Investors to Contact Law Firm

Retrieved on:

Venerdì, Settembre 15, 2023

NextGen Healthcare, AgeX Therapeutics, PLLC, Wall Street, Grupo Argos, Thoma Bravo, Acer, Fraud, Therapy, Contingent value rights, Security (finance), Bank, Zebra

Moore Kuehn may seek increased consideration, additional disclosures, or other relief on behalf of the shareholders of these companies.

Key Points:

Moore Kuehn may seek increased consideration, additional disclosures, or other relief on behalf of the shareholders of these companies.
Under the proposed transaction, AgeX Therapeutics shareholders are expected to own approximately 25% of the combined company.
Moore Kuehn encourages shareholders who would like to discuss their rights to contact Justin Kuehn, Esq.
Moore Kuehn is a 5-star Google client-rated New York City law firm with attorneys representing investors and consumers in litigation involving securities laws, fraud, breaches of fiduciary duties, and other claims.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NXGN, AEL, NEWR

Retrieved on:

Martedì, Settembre 12, 2023

NextGen Healthcare, Nextgen, Sale, Brookfield (corporation), Advertising, Francisco Partners, Thoma Bravo, Fraud, NYSE, Security (finance), New Relic

If you are a NextGen shareholder, click here to learn more about your rights and options .

Key Points:

If you are a NextGen shareholder, click here to learn more about your rights and options .
If you are an American Equity shareholder, click here to learn more about your rights and options .
Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected] .
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.

ALERT: The M&A Class Action Firm Continues Investigating the Merger – TWNK, AVTA, WRK, NXGN

Retrieved on:

Martedì, Settembre 12, 2023

NextGen Healthcare, WestRock, Hostess Brands, Empire, Sale, Acquisition, Thoma Bravo, Monteverde, AVTA, The J.M. Smucker Company, WRK, NYSE, Security (finance), Smucker

Under the terms of the tender offer, TWNK shareholders are expected to receive 0.03002 shares of Smucker and $30.00 in cash per share they own.

Key Points:

Under the terms of the tender offer, TWNK shareholders are expected to receive 0.03002 shares of Smucker and $30.00 in cash per share they own.
It is free and there is no cost or obligation to you.
Under the terms of the agreement, AVTA shareholders are expected to receive $26.00 in cash per share they own.
Under the terms of the agreement, NXGN shareholders are expected to receive $23.95 in cash per share they own.

SHAREHOLDER NEWS: Johnson Fistel Investigates Proposed Sale of NextGen Healthcare; Are NXGN Shareholders Getting a Fair Deal?

Retrieved on:

Giovedì, Settembre 7, 2023

NextGen Healthcare, Learning, Sale, LLP, Nextgen, Acquisition, SAN, Thoma Bravo

SAN DIEGO, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of NextGen Healthcare, Inc. (NASDAQ: NXGN) (“NextGen”) breached their fiduciary duties in connection with the proposed sale of the Company to Thoma Bravo.

Key Points:

SAN DIEGO, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of NextGen Healthcare, Inc. (NASDAQ: NXGN) (“NextGen”) breached their fiduciary duties in connection with the proposed sale of the Company to Thoma Bravo.
You can click or copy and paste the following link to join this investigation:
On September 6, 2023, NextGen announced that it had entered a deal to be purchased by Thoma Bravo.
Under the terms of this agreement, shareholders will receive $23.95 per share in an all-cash offer.
Nationally recognized, Johnson Fistel is investigating whether the proposed deal represents adequate consideration, especially given analysts' projections for future earnings and revenue growth.